Hany Elmariah

机构：Moffitt Cancer Center, Stanford Medicine, Stanford University · ORCID：0000-0001-7920-4636

发表论文 202 篇 · 总被引 2415 次 · h-index 23

代表论文

Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703 (2025 · Blood Advances · 被引 15)
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology (2025 · Journal of the National Comprehensive Cancer Network · 被引 11)
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant (2025 · medRxiv · 被引 10)
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703 (2025 · Journal of Clinical Oncology · 被引 7)
Melphalan Dose in Combination With Fludarabine Affects Gastrointestinal Toxicity and Graft-Versus-Host Disease After Allogeneic Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndromes (2024 · Transplantation and Cellular Therapy · 被引 6)
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results (2024 · Blood · 被引 5)